Contract Changes [4181BJ, 2022-04-01]
|
|
40
|
|
|
4181BJ
|
|
|
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB (C)
|
|
|
|
|
|
16ML VIAL
|
|
|
C
|
|
|
3811.28
|
|
|
|
|
|
2022-04-01
|
|
|
2023-03-31
|
|
|
Delete from contract
|
|
|
2023-03-07
|